Table 2.
Differences in gene expression levels through time in 73 B-ALL patients.
| Gene |
Times included in the comparison and significant P values |
||
|---|---|---|---|
| Time 1/time 2 | Time 1/time 3 | Time 2/time 3 | |
| IL2RA | 0.011 | ns | ns |
| IL10 | 0.012 | ns | ns |
| CD10 | 0.016 | ns | ns |
| CD3D | 0.018 | ns | ns |
| HOXA9 | 0.041 | ns | ns |
| PAX5 | 0.006 | ns | ns |
| CTNNB | ns | 0.039 | ns |
| GSK3B | ns | 0.003 | ns |
| JAK2 | ns | 0.032 | ns |
| FOS1 | ns | 0.007 | ns |
| RAPGEF2 | ns | 0.044 | ns |
| SORT1 | ns | 0.023 | ns |
| HK2 | ns | 0.007 | ns |
| PAX5 | ns | 0.002 | ns |
| DEFA1 | ns | 0.011 | ns |
| NOTCH1 | ns | 0.026 | ns |
| S100A8 | ns | 0.002 | ns |
| ns | ns | 0.037 | |
| BCL11A | 0.023 | ns | ns |
| ns | 0.012 | ns | |
| STAT5 | 0.017 | ns | ns |
| ns | 0.012 | ns | |
| OPAL1 | 0.04 | ns | ns |
| ns | 0.018 | ns | |
| FLT3 | <0.001 | ns | ns |
| ns | 0.009 | ns | |
| RXRA | 0.01 | ns | ns |
| ns | 0.002 | ns | |
| BCL2A | 0.005 | ns | ns |
| ns | <0.001 | ns | |
| ns | ns | 0.005 | |
ns: nonsignificant, P value >0.05.